Advancing Cell Therapy With IntegriCell™ Automated Cryopreservation
Presented by Alexandre Michaux, Ph.D.
Discover how Cryoport Systems is revolutionizing cell therapy with IntegriCell™ Automated Cryopreservation. This presentation highlights our cutting-edge approach to enhancing cryopreservation through automated closed systems, ensuring high cell viability and recovery from various donor-derived leukaphereses.
Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.
Our GMP-compatible automated cryopreservation service sets new benchmarks for consistency and batch-to-batch reliability, enabling the smooth integration of cryopreserved materials into the global cell therapy supply chain. Join us as we examine IntegriCell™'s transformative role in advancing therapeutic applications from collection to clinical use.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.